CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -85.7% | 239 | -89.4% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 2,264 | -14.7% | 0.00% | – |
| Q3 2021 | $9,000 | -18.2% | 2,653 | -0.1% | 0.00% | – |
| Q2 2021 | $11,000 | +450.0% | 2,656 | +2131.9% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 119 | +29.3% | 0.00% | – |
| Q3 2020 | $1,000 | -96.6% | 92 | -96.8% | 0.00% | – |
| Q2 2020 | $29,000 | +93.3% | 2,901 | +181.7% | 0.00% | – |
| Q3 2018 | $15,000 | -97.3% | 1,030 | -96.9% | 0.00% | -100.0% |
| Q2 2018 | $560,000 | -25.5% | 33,261 | +1.3% | 0.00% | 0.0% |
| Q1 2018 | $752,000 | +32.6% | 32,821 | +49.7% | 0.00% | 0.0% |
| Q4 2017 | $567,000 | +18800.0% | 21,923 | +10861.5% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 200 | +78.6% | 0.00% | – |
| Q4 2015 | $2,000 | -81.8% | 112 | -84.2% | 0.00% | – |
| Q2 2015 | $11,000 | 0.0% | 709 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | 0.0% | 709 | -14.1% | 0.00% | – |
| Q4 2014 | $11,000 | – | 825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |